George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Successful First Road Surface Trial Results

1 Apr 2019 07:00

RNS Number : 5763U
Directa Plus PLC
01 April 2019
 

1 April 2019

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Successful First Road Surface Trial Results

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, and its partner Iterchimica, an Italian based world leader in products that enhance asphalt performance, are pleased to announce the first official results from the trial re-surfacing of a section of an Italian road with the G+ upgraded asphalt super modifier containing Directa Plus G+ graphene.

 

The trial was the first commercial test of an asphalt concrete with this innovative graphene-enhanced super modifier and involved the refurbishment of the two upper layers of a 1 km-long section of an Italian road. It was carried out by Iterchimica with support from an independent laboratory. The performance of the road surface has been constantly monitored since last November.

 

The trial, comparing asphalt concrete with the super modifier to a traditional asphalt surfacing, was successful in all respects:

 

· Service life - fatigue resistance improvement was measured at over 250 per cent;

 

· Resistance to the passage of vehicles - mechanical tests showed an Indirect Tensile Strength increase of 35 per cent;

 

· Resistance to deformation at the same load - Stiffness Modulus was measured at different temperatures, showing an improvement of 46 per cent at 40°C;

 

· Permanent plastic deformation - rutting values (track left by tyres) was 35 per cent lower at 60°C.

 

As a result of the successful trial, Directa Plus and Iterchimica are now starting discussions to replicate the trial in new locations in Italy and in other territories including the UK, the US and Oman. 

 

The graphene-enhanced super modifier is the result of a three-year research program called "Ecopave Project" with a patent filed in 2017. New technologies such as the super modifier and the rejuvenation of old paving will help to meet Italy's Green and Circular Economy standards. Once laid, asphalt concrete with super modifier can be 100 per cent recycled, which can reduce the extraction of new materials from quarries and first-use bitumen.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This trial has proven that the G+ upgraded asphalt supermodifier, is suitable for high-traffic roads, highways, airports, and ports. The product perfectly matches Directa Plus's and Iterchimica's vision by offering an innovative, environmentally friendly and sustainable solution to the challenge of reducing the carbon footprint of road surfacing and resurfacing."

 

Federica Giannattasio, CEO of Iterchimica, added: "Road tests were made with the purpose of validating the excellent results obtained in the laboratory - at least + 250% resistance to fatigue - and represent a further step towards the goals that we have set: recycled and 100% recyclable roads that are produced at low temperatures, long-lasting, without potholes and environmentally friendly. After the first results of the trial section that took place in Rome we are ready to trial this new technology in the United States of America, in Oman and in the United Kingdom where we expect to obtain similar results."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Sophie Praill, Edward Lee

 

 

This announcement has been released by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

About Iterchimica

Iterchimica, an Italian based world leader in products that enhance both asphalt pavements performance and the laying of road surfaces in order to increase safety, environmental sustainability, and efficiency.

http://www.iterchimica.it/en/

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKDFDLKNEFF
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.